CoreLab Partners Completes First TQT Study in Japan

PRINCETON, N.J., Oct. 6, 2010 — CoreLab Partners, Inc, the global entity resulting from the merger between RadPharm and Medifacts International in February of this year, has recently completed the first ever regulatory mandated Thorough QT (TQT) study conducted in the Asia Pacific Rim and the f…

Fresenius Medical Care, N.A. Has Selected VitalRemedyMD’s VitalProteinRx(TM) As Its Bar of Choice for Protein Replacement in Dialysis Patients

VitalProteinRx is a state-of-the-art medical food designed to provide highly concentrated quality protein specifically for patients on dialysis and those with diabetes
BOCA RATON, Fla., Oct. 9, 2009 — VitalRemedyMD, a physician-established company, offers scientifically formulated int…